Green Tea Catechins Modulate Skeletal Development with Effects Dependent on Dose, Time, and Structure in a down...

Area of Science:

• Skeletal Biology
• Developmental Biology
• Genetics

Background:

• Down syndrome (DS) is characterized by altered skeletal development, including facial dysmorphies and reduced bone mineral density (BMD).
• Previous research indicated low-dose green tea extract enriched in epigallocatechin-3-gallate (GTE-EGCG) ameliorated facial features in a DS mouse model, while high doses exacerbated them.

Purpose of the Study:

• To systematically evaluate the effects of low and high doses of GTE-EGCG on postnatal skeletal development in wild-type (WT) and Ts65Dn (TS) mice.
• To analyze impacts on facial morphology, long bones (humerus, scapula), and BMD across different developmental timepoints.

Main Methods:

• In vivo micro-computed tomography (µCT) and geometric morphometrics were employed.
• TS and WT mice were treated with low or high doses of GTE-EGCG from embryonic day 9 to postnatal day 29.
• Skeletal structures were analyzed dynamically over time.

Main Results:

• TS mice exhibited shorter, wider faces, skulls, and mandibles, alongside shorter, narrower humerus and scapula, and reduced BMD.
• GTE-EGCG did not rescue skeletal phenotypes in TS mice beyond facial morphology.
• In WT mice, GTE-EGCG altered skull and mandible shape, reduced long bone dimensions, and lowered BMD.

Conclusions:

• The effects of GTE-EGCG on skeletal development are dose-dependent, time-specific, and anatomically variable.
• GTE-EGCG did not universally rescue skeletal deficits in the DS mouse model.
• Further research is needed to understand the complex, multifaceted effects of GTE-EGCG supplementation in DS.